Red Blood Cell Distribution Width Associated With Hospitalized Adults with SARS-CoV-2 Infection

Blood test predicts increased mortality risk in patients with COVID-19
red blood cells

A standard test that assesses blood cells can identify which patients who are admitted to the hospital with COVID-19 face a high-risk of becoming critically ill and dying, said a team of investigators at Massachusetts General Hospital (MGH).

This discovery is described in JAMA Network Open on September 23, 2020, included all adults diagnosed with SARS-CoV-2 infection and admitted to one of four hospitals in the Boston area between March 4 and April 28, 2020. 

Before looking for complicated changes in circulating blood cells in the 1,641 patients included in the study, the scientists first searched for patterns using currently available blood tests that are routinely performed. 

"We were surprised to find that one standard test that quantifies the variation in size of red blood cells--called red cell distribution width (RDW) was highly correlated with patient mortality, and the correlation persisted when controlling for other identified risk factors like patient age, some other lab tests, and some pre-existing illnesses," said co-author Jonathan Carlson, M.D., Ph.D., in a press statement.

Patients who had RDW values above the normal range when they were admitted to the hospital had a 2.7-times higher risk of dying, with a mortality rate of 31 percent compared with 11 percent in patients with normal RDW values. 

Also, a subsequent increase in RDW after admission was associated with an even higher risk of dying, indicating that RDW could be tracked during hospitalization to help determine whether patients are responding to treatment or getting worse.

"We wanted to help find ways to identify high-risk COVID patients as early as possible--who is likely to become severely ill and may benefit from aggressive interventions, and which hospitalized patients are likely to get worse most quickly," said senior author John M. Higgins, M.D.

Dr. Higgins noted that early reports from China indicated that the body's inflammatory response was extremely intense in some patients and very mild in others. His own group's previous work revealed that certain changes in the numbers and types of blood cells during inflammation are associated with poor health outcomes in patients with diseases such as heart disease, cancer, and diabetes.

The investigators are currently seeking to uncover the mechanisms that cause RDW elevations in severe COVID-19 cases. 

Massachusetts General Hospital, founded in 1811, is the largest teaching hospital of Harvard Medical School.

CoronavirusToday publishes research-based COVID-19 pandemic news.